US Stock MarketDetailed Quotes
BCDA BioCardia
- 2.365
- -0.035-1.46%
Trading Nov 7 14:37 ET
8.28MMarket Cap-443P/E (TTM)
2.425High2.340Low28.69KVolume2.400Open2.400Pre Close67.79KTurnover1.09%Turnover RatioLossP/E (Static)3.50MShares23.25052wk High-4.22P/B6.23MFloat Cap1.95652wk Low--Dividend TTM2.63MShs Float129.000Historical High--Div YieldTTM3.55%Amplitude1.956Historical Low2.363Avg Price1Lot Size
BioCardia Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -93.02%3K | -14.06%55K | -64.72%477K | -87.74%13K | 68.40%357K | -95.59%43K | 6.67%64K | 33.20%1.35M | 34.18%106K | -74.18%212K |
| Operating revenue | -93.02%3K | -14.06%55K | -64.72%477K | -87.74%13K | 68.40%357K | -95.59%43K | 6.67%64K | 33.20%1.35M | 34.18%106K | -74.18%212K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -52.73%1.65M | -34.81%2.33M | -8.54%12.12M | -32.87%2.1M | -9.69%2.96M | 0.72%3.5M | 5.52%3.57M | -2.87%13.25M | -11.75%3.12M | -7.28%3.27M |
| Selling and administrative expenses | -27.86%852K | -8.49%1.09M | -0.54%4.4M | 1.84%941K | -3.99%1.08M | 1.29%1.18M | -0.92%1.19M | -13.13%4.42M | -35.16%924K | -12.49%1.13M |
| Research and development costs | -65.43%800K | -47.94%1.24M | -12.54%7.73M | -47.45%1.16M | -12.69%1.87M | 0.43%2.31M | 9.06%2.38M | 3.23%8.83M | 4.02%2.2M | -4.29%2.14M |
| Operating profit | 52.23%-1.65M | 35.19%-2.28M | 2.16%-11.64M | 30.95%-2.08M | 15.10%-2.6M | -38.30%-3.45M | -5.50%-3.51M | 5.77%-11.9M | 12.80%-3.02M | -13.00%-3.06M |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | -89.29%3K | -11.11%8K | 1,316.67%73K | 220.00%12K | 700.00%24K | 2,900.00%28K | 350.00%9K | -185.71%-6K | -10K | 50.00%3K |
| Other non- operating income (expenses) | -89.29%3K | -11.11%8K | 1,316.67%73K | 220.00%12K | 700.00%24K | 2,900.00%28K | 350.00%9K | -185.71%-6K | ---10K | 50.00%3K |
| Income before tax | 51.93%-1.65M | 35.25%-2.27M | 2.82%-11.57M | 31.57%-2.07M | 15.80%-2.57M | -37.12%-3.42M | -5.29%-3.5M | 5.67%-11.91M | 12.51%-3.03M | -12.97%-3.06M |
| Income tax | ||||||||||
| Net income | 51.93%-1.65M | 35.25%-2.27M | 2.82%-11.57M | 31.57%-2.07M | 15.80%-2.57M | -37.12%-3.42M | -5.29%-3.5M | 5.67%-11.91M | 12.51%-3.03M | -12.97%-3.06M |
| Net income continuous Operations | 51.93%-1.65M | 35.25%-2.27M | 2.82%-11.57M | 31.57%-2.07M | 15.80%-2.57M | -37.12%-3.42M | -5.29%-3.5M | 5.67%-11.91M | 12.51%-3.03M | -12.97%-3.06M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 51.93%-1.65M | 35.25%-2.27M | 2.82%-11.57M | 31.57%-2.07M | 15.80%-2.57M | -37.12%-3.42M | -5.29%-3.5M | 5.67%-11.91M | 12.51%-3.03M | -12.97%-3.06M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 51.93%-1.65M | 35.25%-2.27M | 2.82%-11.57M | 31.57%-2.07M | 15.80%-2.57M | -37.12%-3.42M | -5.29%-3.5M | 5.67%-11.91M | 12.51%-3.03M | -12.97%-3.06M |
| Basic earnings per share | 65.08%-0.88 | 47.06%-1.35 | 17.91%-8.25 | 43.75%-1.35 | 29.41%-1.8 | -20.00%-2.52 | 10.53%-2.55 | 10.67%-10.05 | 23.81%-2.4 | -6.25%-2.55 |
| Diluted earnings per share | 65.08%-0.88 | 47.06%-1.35 | 17.91%-8.25 | 43.75%-1.35 | 29.41%-1.8 | -20.00%-2.52 | 10.53%-2.55 | 10.67%-10.05 | 23.81%-2.4 | -6.25%-2.55 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data